Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam S Chang

Showing results (121-130 of 489) with videos related to

Pageof 49
Sort By:
The Journal of Urology|July 22, 2015
Re: Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder CancerSam S Chang
The Journal of Urology|April 22, 2015
Re: Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysisSam S Chang
The Journal of Urology|November 16, 2016
Re: Atezolizumab in Patients with Locally Advanced and Metastatic Urothelial Carcinoma Who Have Progressed following Treatment with Platinum-Based Chemotherapy: A Single-Arm, Multicentre, Phase 2 TrialSam S Chang
The Journal of Urology|November 16, 2016
Re: Practical Tips for Safe and Efficient Robotic CystectomySam S Chang
The Journal of Urology|December 17, 2016
Re: PET/Computed Tomography in Renal, Bladder, and Testicular CancerSam S Chang
The Journal of Urology|October 19, 2016
Re: A Systematic Review and Meta-Analysis of Clinicopathologic Factors Linked to Intravesical Recurrence after Radical Nephroureterectomy to Treat Upper Tract Urothelial CarcinomaSam S Chang
The Journal of Urology|January 18, 2017
Re: Comprehensive Genomic Profiling of 295 Cases of Clinically Advanced Urothelial Carcinoma of the Urinary Bladder Reveals a High Frequency of Clinically Relevant Genomic AlterationsSam S Chang
The Journal of Urology|January 18, 2017
Re: DaPeCa-1: Diagnostic Accuracy of Sentinel Lymph Node Biopsy in 222 Patients with Penile Cancer at Four Tertiary Referral Centres-A National Study from DenmarkSam S Chang
Current Urology Reports|September 23, 2003
Laparoscopic radical nephrectomy: when minimally invasive surgery may be too invasiveSam S Chang
The Journal of Urology|March 14, 2019
Re: Safety and Efficacy of Temsirolimus as Second Line Treatment for Patients with Recurrent Bladder CancerSam S Chang
Pageof 49

Showing results (121-130 of 489) with videos related to

Sort By:
Pageof 49
The Journal of Urology|July 22, 2015
Re: Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder CancerSam S Chang
The Journal of Urology|April 22, 2015
Re: Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysisSam S Chang
The Journal of Urology|November 16, 2016
Re: Atezolizumab in Patients with Locally Advanced and Metastatic Urothelial Carcinoma Who Have Progressed following Treatment with Platinum-Based Chemotherapy: A Single-Arm, Multicentre, Phase 2 TrialSam S Chang
The Journal of Urology|November 16, 2016
Re: Practical Tips for Safe and Efficient Robotic CystectomySam S Chang
The Journal of Urology|December 17, 2016
Re: PET/Computed Tomography in Renal, Bladder, and Testicular CancerSam S Chang
The Journal of Urology|October 19, 2016
Re: A Systematic Review and Meta-Analysis of Clinicopathologic Factors Linked to Intravesical Recurrence after Radical Nephroureterectomy to Treat Upper Tract Urothelial CarcinomaSam S Chang
The Journal of Urology|January 18, 2017
Re: Comprehensive Genomic Profiling of 295 Cases of Clinically Advanced Urothelial Carcinoma of the Urinary Bladder Reveals a High Frequency of Clinically Relevant Genomic AlterationsSam S Chang
The Journal of Urology|January 18, 2017
Re: DaPeCa-1: Diagnostic Accuracy of Sentinel Lymph Node Biopsy in 222 Patients with Penile Cancer at Four Tertiary Referral Centres-A National Study from DenmarkSam S Chang
Current Urology Reports|September 23, 2003
Laparoscopic radical nephrectomy: when minimally invasive surgery may be too invasiveSam S Chang
The Journal of Urology|March 14, 2019
Re: Safety and Efficacy of Temsirolimus as Second Line Treatment for Patients with Recurrent Bladder CancerSam S Chang
Pageof 49